PsychonautWiki Archive

Serotonergic psychedelic: Difference between revisions

← Older editNewer edit →
>Kenan
m Revert addition of previously removed image
>Kenan
m Use cite markup
Line 193: Line 193:


==Literature==
==Literature==
* Nichols, D. E. (2016). '''''Psychedelics.''''' ''Pharmacological Reviews'', 68(2), 264-355. https://doi.org/10.1124/pr.115.011478
* {{cite journal|last1=Nichols|first1=D. E.|title=Psychedelics|journal=Pharmacological Reviews|volume=68|issue=2|year=2016|pages=264–355|issn=1521-0081|doi=10.1124/pr.115.011478}}
* Geyer, M. A., Nichols, D. E., & Vollenweider, F. X. (2009). '''''Serotonin-Related Psychedelic Drugs.''''' ''Encyclopedia of Neuroscience''. https://doi.org/10.1016/b978-008045046-9.01160-8
* {{cite journal|last1=Geyer|first1=M.A.|last2=Nichols|first2=D.E.|last3=Vollenweider|first3=F.X.|title=Serotonin-Related Psychedelic Drugs|year=2009|pages=731–738|doi=10.1016/B978-008045046-9.01160-8}}
* Nichols, C. D., & Sanders-Bush, E. (2001). '''''Serotonin Receptor Signaling and Hallucinogenic Drug Action'''''. ''Heffter Rev Psychedelic Res'', 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf
* Nichols, C. D., & Sanders-Bush, E. (2001). "Serotonin Receptor Signaling and Hallucinogenic Drug Action". ''Heffter Rev Psychedelic Res'', 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf
* Halberstadt, A. L. (2015). '''''Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.''''' ''Behavioral Brain Research'', 277, 99–120. https://doi.org/10.1016/j.bbr.2014.07.016  
* {{cite journal|last1=Halberstadt|first1=Adam L.|title=Recent advances in the neuropsychopharmacology of serotonergic hallucinogens|journal=Behavioural Brain Research|volume=277|year=2015|pages=99–120|issn=01664328|doi=10.1016/j.bbr.2014.07.016}}
* Béïque, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007). '''''Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.''''' ''Proceedings of the National Academy of Sciences'', 104(23), 9870-9875. https://doi.org/10.1073/pnas.0700436104  
* {{cite journal|last1=Beique|first1=J.-C.|last2=Imad|first2=M.|last3=Mladenovic|first3=L.|last4=Gingrich|first4=J. A.|last5=Andrade|first5=R.|title=Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex|journal=Proceedings of the National Academy of Sciences|volume=104|issue=23|year=2007|pages=9870–9875|issn=0027-8424|doi=10.1073/pnas.0700436104}}
* Winter, J. C., Fiorella, D. J., Timineri, D. M., Filipink, R. A., Helsley, S. E., & Rabin, R. A. (1999). '''''Serotonergic receptor subtypes and hallucinogen-induced stimulus control'''''. ''Pharmacology Biochemistry and Behavior'', 64(2), 283-293. http://doi.org/10.1016/S0091-3057(99)00063-5.
* {{cite journal|last1=Winter|first1=J.C|last2=Fiorella|first2=D.J|last3=Timineri|first3=D.M|last4=Filipink|first4=R.A|last5=Helsley|first5=S.E|last6=Rabin|first6=R.A|title=Serotonergic Receptor Subtypes and Hallucinogen-Induced Stimulus Control|journal=Pharmacology Biochemistry and Behavior|volume=64|issue=2|year=1999|pages=283–293|issn=00913057|doi=10.1016/S0091-3057(99)00063-5}}
* Nichols, D. E., & Nichols, C. D. (2008). '''''Serotonin Receptors'''''. ''Chemical Reviews'', 108(5), 1614-1641. https://doi.org/10.1021/cr078224o
* {{cite journal|last1=Nichols|first1=David E.|last2=Nichols|first2=Charles D.|title=Serotonin Receptors|journal=Chemical Reviews|volume=108|issue=5|year=2008|pages=1614–1641|issn=0009-2665|doi=10.1021/cr078224o}}
* Nichols, D. E. (2004). '''''Hallucinogens'''''. ''Pharmacology & Therapeutics'', 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002
* {{cite journal|last1=Nichols|first1=David E|title=Hallucinogens|journal=Pharmacology & Therapeutics|volume=101|issue=2|year=2004|pages=131–181|issn=01637258|doi=10.1016/j.pharmthera.2003.11.002}}
* Vollenweider, F. X., & Kometer, M. (2010). '''''The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders'''''. ''Nature Publishing Group'', 11(9), 642–651. https://doi.org/10.1038/nrn2884
* {{cite journal|last1=Vollenweider|first1=Franz X.|last2=Kometer|first2=Michael|title=The neurobiology of psychedelic drugs: implications for the treatment of mood disorders|journal=Nature Reviews Neuroscience|volume=11|issue=9|year=2010|pages=642–651|issn=1471-003X|doi=10.1038/nrn2884}}
* Johansen, P. Ø., & Krebs, T. S. (2015). '''''Psychedelics not linked to mental health problems or suicidal behavior: A population study'''''. ''Journal of Psychopharmacology'', 29(3), 270-279. https://doi.org/10.1177/0269881114568039
* {{cite journal|last1=Johansen|first1=Pål-Ørjan|last2=Krebs|first2=Teri Suzanne|title=Psychedelics not linked to mental health problems or suicidal behavior: A population study|journal=Journal of Psychopharmacology|volume=29|issue=3|year=2015|pages=270–279|issn=0269-8811|doi=10.1177/0269881114568039}}


===Specific Examples===
===Specific Examples===
Retrieved from "http://psy.st/wiki/Serotonergic_psychedelic"